Glycobiology: Global Markets for Diagnostics and Therapeutics

Apr 2023| BIO153B| BCC Publishing

Report Highlights

The global glycobiology market should reach $5.3 billion by 2027 from $3.2 billion in 2022 at a compound annual growth rate (CAGR) of 11.1% for the forecast period of 2022 to 2027.

Report Includes

  • 51 tables
  • An up-to-date overview and analysis of the global markets for glycobiology diagnostics and therapeutics
  • Analyses of the global market trends, with historic revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for glycobiology market, industry growth drivers, and areas of focus to forecast this market into various segments and subsegments
  • Estimation of the actual market size and revenue forecast for global glycobiology market in USD million terms, and corresponding market share analysis by major market segments and region
  • A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates
  • Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines
  • Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides
  • Identification of leading biotechnology companies poised to introduce products during the forecast period, and their impact on the face of the competitive environment
  • Insight into recent industry structure for glycobiology diagnostics and therapeutics, current competitive scenario, clinical trials, ongoing research (R&D) activities, strategic alliances, and COVID-19 impact on the progress of this market
  • Profile descriptions of the major market players, including Agilent Technologies Inc., Bio-Techne, Merck KGaA, Takara Bio Inc. and Waters Corp.

Report Scope

The current report will provide an in-depth look at the glycobiology market. This report analyzes glycobiology market trends with data from 2021, estimates for 2022, projections of compound annual growth rates through 2027 (forecast period of 2022 to 2027), and regional market data. This report will highlight the current and future market potential of glycobiology along with providing a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints, and opportunities will be covered in the current report. The report also covers market projections for 2027 and indicates the market share for key market players.

The scope of the market in this report is segmented into glycobiology segment and region. The segments of glycobiology are: glycobiology therapeutics, glycobiology diagnostics, and glycobiology reagents and tools. The regional markets are North America, Europe, Asia-Pacific, and other world regions (Rest of the World). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India will be covered within their respective regional segments. For market estimates, data will be provided for 2021 as the base year, with forecasts for 2022 and 2027.

Frequently Asked Questions (FAQs)

• The global market for glycobiology is estimated at $3.2 billion in 2022 and is expected to grow at a CAGR of 11.1% to $5.3 billion by 2027.
• The key factors driving the growth of glycobiology market include technological advancements in the analysis of glycans, the rising prevalence of chronic disorders globally, increasing R&D investment by pharma companies and many others.
• The catheters market is segmented based on application and region.
• Glycobiology Therapeutics segment will dominate the market by the end of 2027.
• North America holds the highest share in the market.
• Key companies in the market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Techne, Merck KGaA, Takara Bio Inc. and others.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $3.2 billion
Market size forecast $5.3 billion
Growth rate CAGR of 11.1% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Segment and region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World (ROW)
Countries covered U.S., Canada, Germany, France, U.K, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific
Key Market Drivers
  • Technological Advancements in the Analysis of Glycans
  • Rising Prevalence of Chronic Disorders Globally
  • Increasing R&D Investment by Pharma Companies
  • Challenges in Glycobiology
  • Inorganic Strategies among Market Players
Companies studied
  • AGILENT TECHNOLOGIES INC.
  • AMSBIO LLC.
  • BIO-TECHNE
  • ISOSEP
  • LUDGER LTD.
  • MERCK KGAA
  • NEW ENGLAND BIOLABS
  • TAKARA BIO INC.
  • THERMO FISHER SCIENTIFIC INC.
  • WATERS CORP.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Glycobiology: Global Markets for Diagnostics and Therapeutics123Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Dynamics11Free
Chapter- 4: Market Overview23Free
Chapter- 5: Impact of COVID-19 on Market2Free
Chapter- 6: Glycobiology Therapeutics Market11Free
Chapter- 7: Glycobiology Diagnostics Market 15Free
Chapter- 8: Glycobiology Reagents and Tools Market 11Free
Chapter- 9: Market Breakdown by Region11Free
Chapter- 10: Analysis of Market Opportunities2Free
Chapter- 11: Competitive Landscape1Free
Chapter- 12: Company Profiles26Free
Chapter- 13: Appendix: Acronyms1Free
Published - Sep-2016| Analyst - Marianna Tcherpakov| Code - BIO153A

Report Highlights

The global market for glycobiology will grow from nearly $24.6 billion in 2016 to nearly $50.1 billion by 2021 with a compound annual growth rate (CAGR) of 15.3% for the period of 2016-2021.

Report Includes

  • An overview of the global markets for glycobiology diagnostics and therapeutics.
  • Analyses of market trends, with data from 2015, 2016, and projections of CAGRs through 2021.
  • Analyses of current trends, products, evolving technologies and new glycobiology related platforms in different clinical areas including oncology, immunology, cardiovascular, infectious diseases and neurodegeneration.
  • A look at new tools for synthesizing, modifying and studying oligosaccharides and glycoconjugates.
  • Evaluation of promising candidates for carbohydrate-based diagnostics, drugs and vaccines.
  • Insight into how glycobiology offers enormous untapped potential in the discovery of new therapeutics derived from saccharides or other molecules which target the biosynthesis and function of saccharides.
  • Profiles of major players in the industry.
Glycobiology: Global Markets for Diagnostics and Therapeutics

Single User License: $5500

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS